Pentoxifylline with metformin treatment improves biochemical parameters in patients with nonalcoholic steatohepatitis

BACKGROUND: The progression of the nonalcoholic fatty liver disease to nonalcoholic steatohepatitis (NASH) is multifactorial, and there is still a lack of approved medications for its treatment. The study aimed to evaluate the impact of combined treatment with Pentoxifylline and Metformin on biochem...

Descripción completa

Detalles Bibliográficos
Autores principales: Ćulafić, Milica, Vezmar-Kovačević, Sandra, Dopsaj, Violeta, Oluić, Branislav, Bidžić, Nemanja, Miljković, Branislava, Ćulafić, Đorđe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society of Medical Biochemists of Serbia, Belgrade 2020
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682853/
https://www.ncbi.nlm.nih.gov/pubmed/33269017
http://dx.doi.org/10.2478/jomb-2019-0043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682853/
https://www.ncbi.nlm.nih.gov/pubmed/33269017
http://dx.doi.org/10.2478/jomb-2019-0043

Ejemplares similares